bios

Press Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelinePress Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Press Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell…

6 days ago
Tevogen Bios First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-OwnedTevogen Bios First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned

Tevogen Bios First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned

600% higher market cap per team member when compared to industry average. Source: Mr. Damodaran at the Stern School of…

1 month ago
Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient InnovationTevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is a…

1 month ago
Synata Bios Sylonto Project Awarded $4.5 Million NDRC GrantSynata Bios Sylonto Project Awarded $4.5 Million NDRC Grant

Synata Bios Sylonto Project Awarded $4.5 Million NDRC Grant

WARRENVILLE, Ill., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Synata Bio, a U.S. company delivering turnkey carbon utilization technology to transform…

4 months ago